Table 3 Computed tomography findings and clinical data of pediatric patients with EHPVO
Type 1 | Type 2 | Type 3 | Type 4 | Total | p | |
|---|---|---|---|---|---|---|
No. | 9.2% (7) | 53.9% (41) | 11.8% (9) | 25.0% (19) | 100% (76) | NA |
Age (year)^ | 5.0/4.0 (3.0–12.0) | 5.0/3.5 (1.3–13.0) | 6.0/2.5 (0.7–14.0) | 4.0/3.0 (1.3–14.0) | 5.0/3.0 (0.7–14) | 0.221 |
Gender (F%)∇ | 28.6% (2) | 34.1% (14) | 66.7% (6) | 21.1% (4) | 34.2% (26) | 0.123 |
Course of disease (Y)^ | 2.0/4.8 (0.2–5.0) | 0.7/1.9 (0.0–8.0) | 1.0/4.5 (0.0–6.0) | 1.0/3.9 (0.0–8.0) | 0.8/2.9 (0.0–8.0) | 0.528 |
Interval time ^ | 7/120 (2–35) | 17/16 (1–176) | 27/59 (5–168) | 14/31 (7–194) | 17/21 (1–194) | 0.277 |
Associated malformations (+)∇ | 28.6% (2) | 17.1% (7) | 11.1% (1) | 42.1% (8) | 25% (19) | 0.142 |
Rex recess (mm)^ | 6.5/3.5 (5.0–10.5) | 2.9/1.3 (2.0–4.8) | 1.4/0.4 (0.6–3.0) | NA | 3.0/2.0 (0.6–10.5) | 0.000* |
Diameter of SMV (mm)^ | 7.3/6.5 (5.9–13.7) | 7.0/2.7 (3.5–12.4) | 6.0/1.5 (4.7–11.2) | 6.4/3.1 (2.5–8.5) | 6.4/2.4 (2.5–13.7) | 0.161 |
Diameter of SV (mm)^ | 6.7/3.7 (5.2–11.7)a | 5.0/2.1 (1.9–11.3) | 4.9/1.6 (1.8–7.4) | 4.8/2.0 (2.5–9.3)b | 5.1/2.2 (1.8–11.7) | 0.027* |
Diameter of spleen (cm)^ | 15.3/3.3 (12.1–18.0) | 13.0/4.4 (2.8–21.9) | 11.7/4.3 (8.1–15.4) | 13.2/4.2 (8.8–17.8) | 13.1/4.1 (2.8–21.9) | 0.129 |
Esophageal-gastric varices (+)∇ | 100% (7) | 95.1% (39) | 100% (9) | 100% (19) | 97.4% (74) | 0.625 |
Cavernous transformation of PV (+)∇ | 100% (7) | 92.7% (38) | 100% (9) | 78.9% (15) | 90.8% (69) | 0.173 |
Uncommon portocaval shunt (+)∇ | 14.3% (1) | 29.3% (12) | 33.3% (3) | 15.8% (3) | 25% (19) | 0.568 |
Dilatation of bile duct (+)∇ | 14.3% (1) | 9.8% (4) | 22.2% (2) | 15.8% (3) | 13.2% (10) | 0.757 |
Ascites (+)∇ | NA (0) | 17.1% (7) | 44.4% (4) | 15.8% (3) | 18.4% (14) | 0.123 |